Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Sarcoma 1Neuroblastoma 1Lymphoma 1Dendritic Cell Sarcoma, Interdigitating 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Radiotherapy 30Temozolomide 16Carboplatin 16Chemotherapy, Adjuvant 15Cisplatin 13Vincristine 12Magnetic Resonance Spectroscopy 12Cyclophosphamide 11Etoposide 10Carmustine 10Methotrexate 8Specimen Handling 7Peripheral Blood Stem Cell Transplantation 7Filgrastim 7X-Rays 6Thiotepa 6Surgical Procedures, Operative 6Phantoms, Imaging 6O(6)-benzylguanine 6Lomustine 6Biopsy 6motexafin gadolinium 4Nuclear Medicine Department, Hospital 4Drug Therapy 4Tamoxifen 3Psychiatric Rehabilitation 3Procarbazine 3Neoadjuvant Therapy 3Mental Status and Dementia Tests 3Irinotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Central Nervous System Neoplasms × gallium nitrate × Clear all
NCT00002543 2013-07-18

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
3 enrolled
CNSLymphoidSarcoma

Burkitt Lymphoma, Lymphoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡